Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy NeuroPace stock

Learn how to easily invest in NeuroPace stock.

NeuroPace, Inc
NASDAQ: NPCE - USD
MEDICAL DEVICES
$21.34
-$0.67 (-3.04%)

NeuroPace, Inc is a medical devices business based in the US. NeuroPace shares (NPCE) are listed on the NASDAQ and all prices are listed in US Dollars. NeuroPace employs 153 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in NeuroPace

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NPCE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

NeuroPace stock price (NASDAQ: NPCE)

Use our graph to track the performance of NPCE stocks over time.

NeuroPace shares at a glance

Information last updated 2021-07-28.
52-week range$18.24 - $27.38
50-day moving average $23.62
200-day moving average $23.20
Wall St. target price$28.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy NeuroPace shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy NeuroPace stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NeuroPace financials

Revenue TTM $42.4 million
Gross profit TTM $30.3 million
Return on assets TTM -21.17%
Return on equity TTM 0%
Profit margin -62.17%
Book value N/A
Market capitalisation $510.1 million

TTM: trailing 12 months

Shorting NeuroPace shares

There are currently 614,698 NeuroPace shares held short by investors – that's known as NeuroPace's "short interest". This figure is 2.7% down from 631,871 last month.

There are a few different ways that this level of interest in shorting NeuroPace shares can be evaluated.

NeuroPace's "short interest ratio" (SIR)

NeuroPace's "short interest ratio" (SIR) is the quantity of NeuroPace shares currently shorted divided by the average quantity of NeuroPace shares traded daily (recently around 151777.28395062). NeuroPace's SIR currently stands at 4.05. In other words for every 100,000 NeuroPace shares traded daily on the market, roughly 4050 shares are currently held short.

To gain some more context, you can compare NeuroPace's short interest ratio against those of similar companies.

However NeuroPace's short interest can also be evaluated against the total number of NeuroPace shares, or, against the total number of tradable NeuroPace shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NeuroPace's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 NeuroPace shares in existence, roughly 30 shares are currently held short) or 0.0738% of the tradable shares (for every 100,000 tradable NeuroPace shares, roughly 74 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NeuroPace.

Find out more about how you can short NeuroPace stock.

NeuroPace share dividends

We're not expecting NeuroPace to pay a dividend over the next 12 months.

NeuroPace overview

NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Frequently asked questions

What percentage of NeuroPace is owned by insiders or institutions?
Currently 92.373% of NeuroPace shares are held by insiders and 22.455% by institutions.
How many people work for NeuroPace?
Latest data suggests 153 work at NeuroPace.
When does the fiscal year end for NeuroPace?
NeuroPace's fiscal year ends in December.
Where is NeuroPace based?
NeuroPace's address is: 455 North Bernardo Avenue, Mountain View, CA, United States, 94043

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site